GSK (GSK) Stock Price & Analysis
GSK (GSK) fell 1.93% to USD 49.89 as of September 8, 2026 at 03:31 UTC, according to Nexqual real-time market data.
GSK last closed at USD 49.89; the session ranged USD 49.66–50.06 on volume of 2,284,805 shares. Market capitalization is —, with a 52-week range of USD 39.29–61.7 (NYQ). Source: Nexqual, September 8, 2026 at 03:31 UTC.
Key Statistics (as of September 8, 2026 at 03:31 UTC)
| Price | USD 49.89 |
|---|---|
| Change | ▼ 1.93% (down) |
| Previous Close | USD 49.89 |
| Open | USD 49.89 |
| Day Range | USD 49.66 – 50.06 |
| 52-Week Range | USD 39.29 – 61.7 |
| Volume | 2,284,805 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (GSK)
Nexqual's technical model rates GSK "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 03:31 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 43.98 (neutral) |
| vs SMA50 | Below (USD 51.66) |
| MACD | -0.34 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNY | Sanofi | USD 44.24 | ▼ 0.52% |
| NVS | Novartis AG | USD 159.99 | ▼ 1.52% |
| AZN | AstraZeneca PLC | USD 162.7 | ▲ 0.66% |
| BMY | Bristol-Myers Squibb Company | USD 66.82 | ▼ 1.24% |
| MRK | Merck & Company, Inc. | USD 150.33 | ▼ 0.86% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 03:31 UTC. This page is informational and not investment advice.